Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
Titel:
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
Auteur:
Svenningsson, Anders Frisell, Thomas Burman, Joachim Salzer, Jonatan Fink, Katharina Hallberg, Susanna Hambraeus, Joakim Axelsson, Markus Nimer, Faiez Al Sundström, Peter Gunnarsson, Martin Johansson, Rune Mellergård, Johan Rosenstein, Igal Ayad, Ahmad Sjöblom, Irina Risedal, Anette de Flon, Pierre Gilland, Eric Lindeberg, Jonas Shawket, Fadi Piehl, Fredrik Lycke, Jan